Robert L. Sutherland

8.0k total citations · 1 hit paper
40 papers, 1.3k citations indexed

About

Robert L. Sutherland is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Robert L. Sutherland has authored 40 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 10 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in Robert L. Sutherland's work include Cancer-related Molecular Pathways (8 papers), Estrogen and related hormone effects (7 papers) and Colorectal Cancer Screening and Detection (5 papers). Robert L. Sutherland is often cited by papers focused on Cancer-related Molecular Pathways (8 papers), Estrogen and related hormone effects (7 papers) and Colorectal Cancer Screening and Detection (5 papers). Robert L. Sutherland collaborates with scholars based in Australia, Canada and United Kingdom. Robert L. Sutherland's co-authors include Elizabeth A. Musgrove, Christine S. L. Lee, Darren R. Brenner, Steven J. Heitman, Robert J. Hilsden, Roger R. Reddel, Nauzer Forbes, Dylan E. O’Sullivan, Susanna Town and Alexander Swarbrick and has published in prestigious journals such as Journal of Clinical Oncology, Molecular and Cellular Biology and Cancer Research.

In The Last Decade

Robert L. Sutherland

36 papers receiving 1.2k citations

Hit Papers

Risk Factors for Early-Onset Colorectal Cancer: A Systema... 2021 2026 2022 2024 2021 50 100 150 200

Peers

Robert L. Sutherland
G M Clark United States
Della Makower United States
Julian Peto United Kingdom
Robert L. Sutherland
Citations per year, relative to Robert L. Sutherland Robert L. Sutherland (= 1×) peers Claus Lattrich

Countries citing papers authored by Robert L. Sutherland

Since Specialization
Citations

This map shows the geographic impact of Robert L. Sutherland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Sutherland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Sutherland more than expected).

Fields of papers citing papers by Robert L. Sutherland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert L. Sutherland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Sutherland. The network helps show where Robert L. Sutherland may publish in the future.

Co-authorship network of co-authors of Robert L. Sutherland

This figure shows the co-authorship network connecting the top 25 collaborators of Robert L. Sutherland. A scholar is included among the top collaborators of Robert L. Sutherland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert L. Sutherland. Robert L. Sutherland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sutherland, Robert L., Devon J. Boyne, Darren R. Brenner, & Winson Y. Cheung. (2023). The Impact of BRAF Mutation Status on Survival Outcomes and Treatment Patterns among Metastatic Colorectal Cancer Patients in Alberta, Canada. Cancers. 15(24). 5748–5748. 2 indexed citations
2.
O’Sullivan, Dylan E., Robert L. Sutherland, Susanna Town, et al.. (2021). Risk Factors for Early-Onset Colorectal Cancer: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology. 20(6). 1229–1240.e5. 217 indexed citations breakdown →
3.
Sutherland, Robert L., Devon J. Boyne, Tamer N. Jarada, et al.. (2021). Development and validation of a risk prediction model for high-risk adenomas at the time of first screening colonoscopy among screening aged Canadians. Preventive Medicine. 148. 106563–106563. 1 indexed citations
4.
Forbes, Nauzer, Devon J. Boyne, Matthew Mazurek, et al.. (2020). Association Between Endoscopist Annual Procedure Volume and Colonoscopy Quality: Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology. 18(10). 2192–2208.e12. 29 indexed citations
5.
Millar, Ewan K.A., Peter Graham, Catriona M. McNeil, et al.. (2011). Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53. British Journal of Cancer. 105(2). 272–280. 55 indexed citations
6.
Caldon, C. Elizabeth, et al.. (2008). The Helix-Loop-Helix Protein Id1 Requires Cyclin D1 to Promote the Proliferation of Mammary Epithelial Cell Acini. Cancer Research. 68(8). 3026–3036. 24 indexed citations
7.
DeFazio, Anna, et al.. (2000). Expression of c‐erbB receptors, heregulin and oestrogen receptor in human breast cell lines. International Journal of Cancer. 87(4). 487–498. 7 indexed citations
8.
Douglas, Andrea M., et al.. (1998). Oncostatin M induces the differentiation of breast cancer cells. International Journal of Cancer. 75(1). 64–73. 67 indexed citations
9.
Janes, Peter W., et al.. (1998). Inhibition of the MAP kinase cascade blocks heregulin-induced cell cycle progression in T-47D human breast cancer cells. Oncogene. 16(21). 2803–2813. 61 indexed citations
10.
Sweeney, Kimberley J. E., et al.. (1998). Lack of relationship between CDK activity and G1 cyclin expression in breast cancer cells. Oncogene. 16(22). 2865–2878. 71 indexed citations
11.
Sutherland, Robert L., et al.. (1997). Identification of PRG1, A Novel Progestin-Responsive Gene with Sequence Homology to 6-Phosphofructo-2-Kinase/Fructose- 2,6-Bisphosphatase. Molecular Endocrinology. 11(4). 490–502. 50 indexed citations
12.
Šarčević, Boris, et al.. (1996). Cancer-associated mis-sense and deletion mutations impair p16INK4 CDK inhibitory activity. International Journal of Cancer. 66(2). 249–254. 61 indexed citations
13.
Lee, Christine S. L., Anna DeFazio, Christopher J. Ormandy, & Robert L. Sutherland. (1996). Inverse regulation of oestrogen receptor and epidermal growth factor receptor gene expression in MCF-7 breast cancer cells treated with phorbol ester. The Journal of Steroid Biochemistry and Molecular Biology. 58(3). 267–275. 17 indexed citations
14.
Musgrove, Elizabeth A., et al.. (1995). Expression of the cyclin‐dependent kinase inhibitors p16INK4, p15INK4B and p21Waf1/cip1 in human breast cancer. International Journal of Cancer. 63(4). 584–591. 67 indexed citations
15.
Sutherland, Robert L., et al.. (1995). Expression and Regulation of Cyclin Genes in Breast Cancer. Acta Oncologica. 34(5). 651–656. 27 indexed citations
16.
Watts, Colin, M. Händel, R.J.B. King, & Robert L. Sutherland. (1992). Oestrogen receptor gene structure and function in breast cancer. The Journal of Steroid Biochemistry and Molecular Biology. 41(3-8). 529–536. 39 indexed citations
17.
Ormandy, Christopher J., et al.. (1992). The Effect of Progestins on Prolactin Receptor Gene Transcription in Human Breast Cancer Cells. DNA and Cell Biology. 11(10). 721–726. 17 indexed citations
18.
Ormandy, Christopher J., et al.. (1988). Human Growth Hormone Binds to Lactogenic Receptors in Bovine, Ovine and Rat Adrenals. Hormone and Metabolic Research. 20(5). 278–281. 2 indexed citations
19.
Reddel, Roger R. & Robert L. Sutherland. (1987). Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro.. PubMed. 47(20). 5323–9. 58 indexed citations
20.
Sutherland, Robert L., et al.. (1960). VARIATIONS BETWEEN NEGROES AND WHITES IN CONCEPTS OF MENTAL ILLNESS AND ITS TREATMENT*. Annals of the New York Academy of Sciences. 84(17). 918–937. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026